RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 6 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Changes in FDA Inspections, Responses and Compliances

Changes in FDA Inspections, Responses and Compliances

Posted 01 July 2011 | By Alok Byopadhyay PhD RAC 

Contamination of imported food and drug products has prompted the US Food and Drug Administration (FDA) to examine incidents involving the substitution of ingredients in food and drugs to increase profits.1 This contributed to the passage of the Food and Drug Globalization Act of 2009 by the 111th Congress, which amends the Food, Drug, and Cosmetic Act (FDA&C Act) to improve the safety of food, drugs, devices and cosmetics in the global market.2 This article discusses the changes in FDA's new enforcement strategies following the passage of Globalization Act and the remedies of these actions.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe